In This Article:
BTIG raised the firm’s price target on HealthEquity (HQY) to $130 from $110 and keeps a Buy rating on the shares. The firm is citing improving policy fundamentals, better visibility into demand trends, and a healthy economy and labor market in updating its model, the analyst tells investors in a research note. BTIG adds that as health-tech and services moves closer to the consumer with digital products, HealthEquity’s incoming CEO Scott Cutler will help facilitate growth.
Don't Miss our Black Friday Offers:
-
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
-
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY: